Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. Formerly part of GE Healthcare Life Sciences, we have a rich heritage tracing back hundreds of years, and a fresh beginning since 2020. Cytiva customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies. Cytiva is a 3.3 billion USD global life sciences leader with over 7000 dedicated associates across 40 sites providing leading products including the Hyclone brand of cell culture products, Akta range of protein purification solutions, Biacore protein interaction analysis, as well as a full range of Western Blot and Genomics reagents, Gel Imaging systems, High Content Screening instruments, and much more.